Hypoxic Ischemic Encephalopathy (HIE) - Epidemiology Forecast to 2032

January 2022 | 60 pages | ID: HF9E0AE6ED24EN
DelveInsight

Abstracts

This report can be delivered to the clients within 5-7 Business Days

DelveInsight's 'Hypoxic Ischemic Encephalopathy (HIE) - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Hypoxic Ischemic Encephalopathy (HIE) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Geographies Covered

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2019-2032

Hypoxic Ischemic Encephalopathy (HIE) Understanding

The DelveInsight Hypoxic Ischemic Encephalopathy (HIE) epidemiology report gives a thorough understanding of the Hypoxic Ischemic Encephalopathy (HIE) by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Hypoxic Ischemic Encephalopathy (HIE) in the US, Europe, and Japan. The report covers the detailed information of the Hypoxic Ischemic Encephalopathy (HIE) epidemiology scenario in seven major countries (US, EU5, and Japan).

Hypoxic Ischemic Encephalopathy (HIE) Epidemiology Perspective by DelveInsight

The Hypoxic Ischemic Encephalopathy (HIE) epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Hypoxic Ischemic Encephalopathy (HIE) epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Hypoxic Ischemic Encephalopathy (HIE) epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2019 to 2032. It also helps recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Hypoxic Ischemic Encephalopathy (HIE) Detailed Epidemiology Segmentation

The Hypoxic Ischemic Encephalopathy (HIE) epidemiology covered in the report provides historical as well as forecasted Hypoxic Ischemic Encephalopathy (HIE) epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2019 to 2032.

The DelveInsight Hypoxic Ischemic Encephalopathy (HIE) report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

Scope of the Report

• The Hypoxic Ischemic Encephalopathy (HIE) report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• The Hypoxic Ischemic Encephalopathy (HIE) Epidemiology Report and Model provide an overview of the global trends of Hypoxic Ischemic Encephalopathy (HIE) in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
• The report provides insight into the historical and forecasted patient pool of Hypoxic Ischemic Encephalopathy (HIE) in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
• The report helps recognize the growth opportunities in the 7MM for the patient population
• The report assesses the disease risk and burden and highlights the unmet needs of Hypoxic Ischemic Encephalopathy (HIE)
• The report provides the segmentation of the Hypoxic Ischemic Encephalopathy (HIE) epidemiology

Report Highlights

• 11-year Forecast of Hypoxic Ischemic Encephalopathy (HIE) epidemiology
• 7MM Coverage
• Prevalent and Diagnosed Cases of Hypoxic Ischemic Encephalopathy (HIE)
• Cases of Hypoxic Ischemic Encephalopathy (HIE) by Mutation Types
• Hypoxic Ischemic Encephalopathy (HIE) Cases associated with Clinical Manifestations

KOL views

We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

• What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Hypoxic Ischemic Encephalopathy (HIE)?
• What are the key findings pertaining to the Hypoxic Ischemic Encephalopathy (HIE) epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2019-2032)?
• What would be the total number of patients of Hypoxic Ischemic Encephalopathy (HIE) across the 7MM during the forecast period (2019-2032)?
• Among the EU5 countries, which country will have the highest number of patients during the forecast period (2019-2032)?
• At what CAGR the patient population is expected to grow in 7MM during the forecast period (2019-2032)?
• What is the disease risk, burden and unmet needs of Hypoxic Ischemic Encephalopathy (HIE)?
• What are the currently available treatments of Hypoxic Ischemic Encephalopathy (HIE)?

Reasons to buy

The Hypoxic Ischemic Encephalopathy (HIE) Epidemiology report will allow the user to -

• Develop business strategies by understanding the trends shaping and driving the global Hypoxic Ischemic Encephalopathy (HIE) market
• Quantify patient populations in the global Hypoxic Ischemic Encephalopathy (HIE) market to improve product design, pricing, and launch plans
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Hypoxic Ischemic Encephalopathy (HIE) therapeutics in each of the markets covered
• Understand the magnitude of Hypoxic Ischemic Encephalopathy (HIE) population by its epidemiology
• The Hypoxic Ischemic Encephalopathy (HIE) Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

Key Assessments

• Patient Segmentation
• Disease Risk & Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population

Contents

1. KEY INSIGHTS

2. EXECUTIVE SUMMARY OF HYPOXIC ISCHEMIC ENCEPHALOPATHY (HIE)

3. HYPOXIC ISCHEMIC ENCEPHALOPATHY (HIE): DISEASE BACKGROUND AND OVERVIEW

3.1. Introduction
3.2. Sign and Symptoms
3.3. Pathophysiology
3.4. Risk Factors
3.5. Diagnosis

4. PATIENT JOURNEY

5. EPIDEMIOLOGY AND PATIENT POPULATION

5.1. Epidemiology Key Findings
5.2. Assumptions and Rationale: 7MM
5.3. Epidemiology Scenario: 7MM
  5.3.1. Hypoxic Ischemic Encephalopathy (HIE) Epidemiology Scenario in the 7MM (2019- 2032)
5.4. United States Epidemiology
  5.4.1. Hypoxic Ischemic Encephalopathy (HIE) Epidemiology Scenario in the United States (2019- 2032)
5.5. EU-5 Country-wise Epidemiology
  5.5.1. Germany Epidemiology
    5.5.1.1. Hypoxic Ischemic Encephalopathy (HIE) Epidemiology Scenario in Germany (2019- 2032)
  5.5.2. France Epidemiology
    5.5.2.1. Hypoxic Ischemic Encephalopathy (HIE) Epidemiology Scenario in France (2019- 2032)
  5.5.3. Italy Epidemiology
    5.5.3.1. Hypoxic Ischemic Encephalopathy (HIE) Epidemiology Scenario in Italy (2019- 2032)
  5.5.4. Spain Epidemiology
    5.5.4.1. Hypoxic Ischemic Encephalopathy (HIE) Epidemiology Scenario in Spain (2019- 2032)
  5.5.5. United Kingdom Epidemiology
    5.5.5.1. Hypoxic Ischemic Encephalopathy (HIE) Epidemiology Scenario in the United Kingdom (2019-2032)
5.6. Japan Epidemiology
  5.6.1. Hypoxic Ischemic Encephalopathy (HIE) Epidemiology Scenario in Japan (2019- 2032)

6. TREATMENT ALGORITHM, CURRENT TREATMENT, AND MEDICAL PRACTICES

6.1. Hypoxic Ischemic Encephalopathy (HIE) Treatment and Management
6.2. Hypoxic Ischemic Encephalopathy (HIE) Treatment Algorithm

7. KOL VIEWS

8. UNMET NEEDS

9. APPENDIX

9.1. Bibliography
9.2. Report Methodology

10. DELVEINSIGHT CAPABILITIES

11. DISCLAIMER

12. ABOUT DELVEINSIGHT

*The table of contents is not exhaustive; will be provided in the final report

List Of Tables

LIST OF TABLES

List of Table:
Table 1: Hypoxic Ischemic Encephalopathy (HIE) Epidemiology in 7MM (2019-2032)
Table 2: Hypoxic Ischemic Encephalopathy (HIE) Diagnosed and Treatable Cases in 7MM (2019-2032)
Table 3: Hypoxic Ischemic Encephalopathy (HIE) Epidemiology in the United States (2019-2032)
Table 4: Hypoxic Ischemic Encephalopathy (HIE) Diagnosed and Treatable Cases in the United States (2019-2032)
Table 5: Hypoxic Ischemic Encephalopathy (HIE) Epidemiology in Germany (2019-2032)
Table 6: Hypoxic Ischemic Encephalopathy (HIE) Diagnosed and Treatable Cases in Germany (2019-2032)
Table 7: Hypoxic Ischemic Encephalopathy (HIE) Epidemiology in France (2019-2032)
Table 8: Hypoxic Ischemic Encephalopathy (HIE) Diagnosed and Treatable Cases in France (2019-2032)
Table 9: Hypoxic Ischemic Encephalopathy (HIE) Epidemiology in Italy (2019-2032)
Table 10: Hypoxic Ischemic Encephalopathy (HIE) Diagnosed and Treatable Cases in Italy (2019-2032)
Table 11: Hypoxic Ischemic Encephalopathy (HIE) Epidemiology in Spain (2019-2032)
Table 12: Hypoxic Ischemic Encephalopathy (HIE) Diagnosed and Treatable Cases in Spain (2019-2032)
Table 13: Hypoxic Ischemic Encephalopathy (HIE) Epidemiology in the United Kingdom (2019-2032)
Table 14: Hypoxic Ischemic Encephalopathy (HIE) Diagnosed and Treatable Cases in the United Kingdom (2019-2032)
Table 15: Hypoxic Ischemic Encephalopathy (HIE) Epidemiology in Japan (2019-2032)
Table 16: Hypoxic Ischemic Encephalopathy (HIE) Diagnosed and Treatable Cases in Japan (2019-2032)

List Of Figures

LIST OF FIGURES

List of Figures
Figure 1 Hypoxic Ischemic Encephalopathy (HIE) Epidemiology in 7MM (2019-2032)
Figure 2 Hypoxic Ischemic Encephalopathy (HIE) Diagnosed and Treatable Cases in 7MM (2019-2032)
Figure 3 Hypoxic Ischemic Encephalopathy (HIE) Epidemiology in the United States (2019-2032)
Figure 4 Hypoxic Ischemic Encephalopathy (HIE) Diagnosed and Treatable Cases in the United States (2019-2032)
Figure 5 Hypoxic Ischemic Encephalopathy (HIE) Epidemiology in Germany (2019-2032)
Figure 6 Hypoxic Ischemic Encephalopathy (HIE) Diagnosed and Treatable Cases in Germany (2019-2032)
Figure 7 Hypoxic Ischemic Encephalopathy (HIE) Epidemiology in France (2019-2032)
Figure 8 Hypoxic Ischemic Encephalopathy (HIE) Diagnosed and Treatable Cases in France (2019-2032)
Figure 9 Hypoxic Ischemic Encephalopathy (HIE) Epidemiology in Italy (2019-2032)
Figure 10 Hypoxic Ischemic Encephalopathy (HIE) Diagnosed and Treatable Cases in Italy (2019-2032)
Figure 11 Hypoxic Ischemic Encephalopathy (HIE) Epidemiology in Spain (2019-2032)
Figure 12 Hypoxic Ischemic Encephalopathy (HIE) Diagnosed and Treatable Cases in Spain (2019-2032)
Figure 13 Hypoxic Ischemic Encephalopathy (HIE) Epidemiology in the United Kingdom (2019-2032)
Figure 14 Hypoxic Ischemic Encephalopathy (HIE) Diagnosed and Treatable Cases in the United Kingdom (2019-2032)
Figure 15 Hypoxic Ischemic Encephalopathy (HIE) Epidemiology in Japan (2019-2032)
Figure 16 Hypoxic Ischemic Encephalopathy (HIE) Diagnosed and Treatable Cases in Japan (2019-2032)
*The table of contents is not exhaustive; will be provided in the final report